Baertschi SW - Search Results

1

The assessment of impurities for genotoxic potential and subsequent control in drug substance and drug product.

Dow LK, Hansen MM, Pack BW, Page TJ, Baertschi SW. Dow LK, et al. Among authors: baertschi sw. J Pharm Sci. 2013 May;102(5):1404-18. doi: 10.1002/jps.23462. Epub 2013 Feb 21. J Pharm Sci. 2013. PMID: 23436613

2

Aqueous acidic degradation of the carbacephalosporin loracarbef.

Skibic MJ, Taylor KW, Occolowitz JL, Collins MW, Paschal JW, Lorenz LJ, Spangle LA, Dorman DE, Baertschi SW. Skibic MJ, et al. Among authors: baertschi sw. J Pharm Sci. 1993 Oct;82(10):1010-7. J Pharm Sci. 1993. PMID: 8254485

3

Isolation and structure elucidation of a novel product of the acidic degradation of cefaclor.

Baertschi SW, Dorman DE, Occolowitz JL, Spangle LA, Collins MW, Wildfeuer ME, Lorenz LJ. Baertschi SW, et al. J Pharm Sci. 1993 Jun;82(6):622-6. doi: 10.1002/jps.2600820616. J Pharm Sci. 1993. PMID: 8331538

4

Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine.

Wirth DD, Baertschi SW, Johnson RA, Maple SR, Miller MS, Hallenbeck DK, Gregg SM. Wirth DD, et al. Among authors: baertschi sw. J Pharm Sci. 1998 Jan;87(1):31-9. doi: 10.1021/js9702067. J Pharm Sci. 1998. PMID: 9452965

5

Characterization of impurities formed by interaction of duloxetine HCl with enteric polymers hydroxypropyl methylcellulose acetate succinate and hydroxypropyl methylcellulose phthalate.

Jansen PJ, Oren PL, Kemp CA, Maple SR, Baertschi SW. Jansen PJ, et al. Among authors: baertschi sw. J Pharm Sci. 1998 Jan;87(1):81-5. doi: 10.1021/js970133r. J Pharm Sci. 1998. PMID: 9452973

6

The degradation of the antitumor agent gemcitabine hydrochloride in an acidic aqueous solution at pH 3.2 and identification of degradation products.

Jansen PJ, Akers MJ, Amos RM, Baertschi SW, Cooke GG, Dorman DE, Kemp CA, Maple SR, McCune KA. Jansen PJ, et al. Among authors: baertschi sw. J Pharm Sci. 2000 Jul;89(7):885-91. doi: 10.1002/1520-6017(200007)89:7<885::AID-JPS5>3.0.CO;2-Q. J Pharm Sci. 2000. PMID: 10861589

7

Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product.

Hartauer KJ, Arbuthnot GN, Baertschi SW, Johnson RA, Luke WD, Pearson NG, Rickard EC, Tingle CA, Tsang PK, Wiens RE. Hartauer KJ, et al. Among authors: baertschi sw. Pharm Dev Technol. 2000;5(3):303-10. doi: 10.1081/pdt-100100545. Pharm Dev Technol. 2000. PMID: 10934729

8

Isolation, identification, and synthesis of two oxidative degradation products of olanzapine (LY170053) in solid oral formulations.

Baertschi SW, Brunner H, Bunnell CA, Cooke GG, Diseroad B, Dorman DE, Jansen PJ, Kemp CA, Maple SR, McCune KA, Speakman JL. Baertschi SW, et al. J Pharm Sci. 2008 Feb;97(2):883-92. doi: 10.1002/jps.21146. J Pharm Sci. 2008. PMID: 17879984

9

A critical assessment of the ICH guideline on photostability testing of new drug substances and products (Q1B): Recommendation for revision.

Baertschi SW, Alsante KM, Tønnesen HH. Baertschi SW, et al. J Pharm Sci. 2010 Jul;99(7):2934-40. doi: 10.1002/jps.22076. J Pharm Sci. 2010. PMID: 20135694

10

Artifactual formylation of the secondary amine of duloxetine hydrochloride by acetonitrile in the presence of titanium dioxide: implications for HPLC method development.

Skibic MJ, King LA, Khan M, Fox PJ, Winger BE, Baertschi SW. Skibic MJ, et al. Among authors: baertschi sw. J Pharm Biomed Anal. 2010 Nov 2;53(3):432-9. doi: 10.1016/j.jpba.2010.05.007. Epub 2010 May 12. J Pharm Biomed Anal. 2010. PMID: 20570459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters